Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study

Published:2020-05-18 Issue:9 Volume:61 Page:2082-2092
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Turunen Antti¹²^ORCID,Valtola Jaakko¹³,Partanen Anu¹,Ropponen Antti⁴,Kuittinen Outi²⁵⁶,Kuitunen Hanne⁶,Vasala Kaija⁷,Ågren Lasse⁸,Penttilä Karri³⁹,Keskinen Leena¹⁰,Savolainen Eeva-Riitta¹¹,Pyörälä Marja¹,Kuittinen Taru¹,Selander Tuomas¹²,Mäntymaa Pentti¹³,Pelkonen Jukka⁴¹³,Jantunen Esa¹²⁸,Varmavuo Ville¹⁴

Affiliation:

1. Department of Medicine, Kuopio University Hospital, Kuopio, Finland;

2. Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland;

3. Department of Medicine, Savonlinna Central Hospital, Savonlinna, Finland;

4. Department of Clinical Microbiology, University of Eastern Finland, Kuopio, Finland;

5. Department of Oncology, Kuopio University Hospital, Kuopio, Finland;

6. Department of Oncology, Oulu University Hospital, Oulu, Finland;

7. Department of Oncology, Central Hospital of Central Finland, Jyväskylä, Finland;

8. Department of Medicine, North Carelia Hospital District, Joensuu, Finland;

9. Finnish Medicines Agency, Kuopio, Finland;

10. Department of Oncology, Tampere University Hospital, Tampere, Finland;

11. Nordlab, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland;

12. Science Service Center, Kuopio University Hospital, Kuopio, Finland;

13. Laboratory Centre of Eastern Finland, Kuopio, Finland;

14. Department of Medicine, Kymenlaakso Central Hospital, Kotka, Finland

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1762879

Reference35 articles.

1. Kinetics of blood CD34+ cells after chemotherapy plus G-CSF in poor mobilizers: Implications for pre-emptive plerixafor use

2. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

3. High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation

4. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation

5. Transplanted CD34+ Cell Dose Is Associated with Long-Term Platelet Count Recovery following Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hodgkin Lymphoma or Multiple Myeloma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Factors for Early Immune Recovery in NHL Patients after Autologous Transplantation: A Multicenter Prospective Study;Cancers;2024-07-16

2. Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation;Transfusion;2024-02-26

3. Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2023-11

4. No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma;Bone Marrow Transplantation;2023-09-04

5. Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors;Transplantation and Cellular Therapy;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3